Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ENPP1 inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 inhibitors), STING1 inhibitors(Stimulator of interferon genes inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - | |
Neoplasms | Preclinical | US | Stingray Therapeutics, Inc.Startup | - |